Sidoti analyst James Sidoti downgraded Staar Surgical (STAA) to Neutral from Buy with a $28 price target after Alcon (ALC) announced a definitive agreement to acquire Staar for $28 per share in cash.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on STAA: